Last week CNN published an investigative report that concluded that Avanir Pharmaceuticals was paying physicians to prescribe its drug, Neudexta, to Alzheimer’s patients under the pretext that these patients have a rare disease. CNN’s research revealed a 400% increase in the sale of Neudexta in the past four years, and Read More…
STAT, the on-line health publication covering medicine, science and health issues, recently sponsored an hour on-line “chat” with Reisa Sperling, the head of the Center for Alzheimer’s Research and Treatment at Brigham & Women’s Hospital. Dr. Sperling answered questions about the state of Alzheimer research and STAT reporters filled out Read More…
